Whitepaper and App Notes

Ultrasensitive Tau Assay Enables Quantification of Neuronal Biomarker in Blood Test for the First Time

Quanterix™ has developed a novel platform that enables the quantification of proteins present in blood and other body fluids at previously undetectable concentrations. The application of this Single Molecule Array (Simoa) technology will provide medical researchers with an unprecedented tool for detecting low-abundance biomarkers and speed the development of a new generation of diagnostic products useful for early detection of disease. Unprecedented analytical sensitivity is the key differentiator of Quanterix’s technology, made possible by its proprietary single-molecule detection technology